Cargando…
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease
Individuals with chronic kidney disease are at an increased risk for cardiovascular disease. This risk may partially be explained by a chronic inflammatory state in these patients, reflected by increased arterial wall and cellular inflammation. Statin treatment decreases cardiovascular risk and arte...
Autores principales: | Hoogeveen, Renate M., Verweij, Simone L., Kaiser, Yannick, Kroon, Jeffrey, Verberne, Hein J., Vogt, Liffert, Moens, Sophie J. Bernelot, Stroes, Erik S. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892998/ https://www.ncbi.nlm.nih.gov/pubmed/33602971 http://dx.doi.org/10.1038/s41598-021-83273-2 |
Ejemplares similares
-
Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with (18)F-DPA-714 PET/CT
por: Verweij, Simone L., et al.
Publicado: (2018) -
Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study
por: Bernelot Moens, Sophie J., et al.
Publicado: (2016) -
Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes
por: Oostveen, Reindert F., et al.
Publicado: (2023) -
Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study
por: Bernelot Moens, Sophie J., et al.
Publicado: (2016) -
Erratum to: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study
por: Bernelot Moens, Sophie J., et al.
Publicado: (2016)